ADVERTISEMENT

Biological E

Japanese pharma giant Takeda & Hyderabad's Biological E join hands to make dengue vaccine

'Together, we will help combat dengue on a global scale by significantly increasing manufacturing capacity for multi-dose vials of TAK-003 to drive sustainable access to the vaccine in more endemic countries,' Takeda's Global Vaccine Business Unit, MD and President Gary Dubin added.

28 February 2024, 06:25 IST

Japanese pharma giant Takeda & Hyderabad's Biological E join hands to make dengue vaccine

Japanese pharma giant Takeda & Hyderabad's Biological E join hands to make dengue vaccine

Japanese pharma giant Takeda & Hyderabad's Biological E join hands to make dengue vaccine

28 February 2024, 06:25 IST

Biological E to invest Rs 1,800 crore in Hyderabad

22 July 2022, 06:19 IST

Biological E to invest Rs 1,800 crore in Hyderabad

Biological E to invest Rs 1,800 crore in Hyderabad

Biological E to invest Rs 1,800 crore in Hyderabad

22 July 2022, 06:19 IST